top of page
Browse by category
Search


Nearly two-thirds of people stop taking weight loss drugs due to side effects and cost
The majority of patients prescribed weight loss drugs for obesity stop taking them because of side effects and cost, according to the...


Lessons from insulin - curbing the price of novel diabetes and obesity medications
For years, Dr Kasia Lipska, associate professor of medicine (endocrinology) at Yale School of Medicine (YSM), has been advocating for...


76% of older adults think Medicare should cover obesity drugs
The vast majority of older adults - 83% - think health insurers should cover medications that can help people with obesity manage their...


Journal Watch 13/12/2023
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...


IFSO Consensus on definitions and clinical practice guidelines (part 1)
In March 2023, the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) organised a Delphi consensus...


Despite new treatment options gaps remain in identifying and treating obesity
A significant fraction of people with obesity or overweight are not getting the recommended care, despite an increase in new treatment...


Aromatase inhibitors may limit effectiveness of weight loss medications
Breast cancer medications such as aromatase inhibitors, may lessen the effect of weight loss drugs, according to a study presented at...


Anti-obesity medications remain prohibitively expensive
Several anti-obesity medications could be manufactured and profitability sold worldwide at far lower estimated lower prices compared to...


Price of anti-obesity medications limits access for those most in need
Recent results from clinical trials and studies assessing anti-obesity medications, in addition regulatory approvals, has resulted in...
Browse by tag






bottom of page

